C. pneumoniae serostatus influences cytokine production patterns in steroid resistant and sensitive asthmatics
D. Paróczai (Deszk, Hungary), T. Mosolygó (Szeged, Hungary), D. Kókai (Szeged, Hungary), I. Lantos (Szeged, Hungary), D. Virok (Szeged, Hungary), Z. Rózsavölgyi (Deszk, Hungary), R. Pálföldi (Deszk, Hungary), A. Somfay (Deszk, Hungary), K. Burián (Szeged, Hungary)
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Paróczai (Deszk, Hungary), T. Mosolygó (Szeged, Hungary), D. Kókai (Szeged, Hungary), I. Lantos (Szeged, Hungary), D. Virok (Szeged, Hungary), Z. Rózsavölgyi (Deszk, Hungary), R. Pálföldi (Deszk, Hungary), A. Somfay (Deszk, Hungary), K. Burián (Szeged, Hungary). C. pneumoniae serostatus influences cytokine production patterns in steroid resistant and sensitive asthmatics. 4395
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Increased Th2 response with C. pneumoniae infection Source: Eur Respir J 2002; 20: Suppl. 38, 311s Year: 2002
Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections Year: 2008
Streptococcus pneumoniae augments inflammatory process in asthma model without changing Th2 profile Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells Source: Eur Respir J 2011; 37: 53-64 Year: 2011
C. pneumoniae alters CD80 expression in monocytes: implications in asthmaSource: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002
Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma Source: Eur Respir J 2002; 20: 834-840 Year: 2002
Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae Source: Eur Respir J 2002; 19: 546-556 Year: 2002
Chlamydia pneumoniae persists in COPD lung tissue: predominant role of toll-like receptor 2 versus 4 in chlamydia pneumoniae -induced activation of pulmonary immune cellsSource: Eur Respir J 2004; 24: Suppl. 48, 240s Year: 2004
Chlamydia pneumoniae infection in asthmatic patients Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009
The commensal bacterium Rothia mucilaginosa has anti-inflammatory properties in vitro and in vivo, and negatively correlates with sputum pro-inflammatory markers in chronic airway disease. Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021
Prevalence of specific IgE antibodies against Mycoplasma pneumoniae and Chlamydia pneumoniae in extrinsic and intrinsic bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 141s Year: 2001
In COPD moxifloxacin enhances th1-immune response in the presence of bacterial endotoxin by inducing IL-2 expression Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009
The balance of pro- and anti - inflammatory cytokines in Chlamydia pneumoniae infected cells as a marker of inflammatory activity in the pulmonary compartment Source: Eur Respir J 2001; 18: Suppl. 33, 154s Year: 2001
LSC Abstract – The host genetic background impacts on pseudomonas aeruginosa-induced T cell responses and individual susceptibility/resistance to respiratory infection Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015
Treatment of patients with bronchial asthma and latent chlamydophila pneumoniae and mycoplasma pneumoniae infections by a doxycycline Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002
Seroprevalance of chlamydia pneumoniae infection in patients with chronic stable asthma as well as its correlation with high eosinophil cationic protein level Source: Eur Respir J 2004; 24: Suppl. 48, 590s Year: 2004
The effect of chlamydia pneumoniae infection on the course of bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 516s Year: 2003
Gender differences in ecg-QT interval variables during macrolide treatment of mycoplasma pneumoniae infection in children Source: Eur Respir J 2006; 28: Suppl. 50, 489s Year: 2006
Chlamydia pneumoniae infection in patients with mild asthma Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
The role of Chlamydia pneumoniae infection in bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 681s Year: 2005